{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T07:18:27Z","timestamp":1788679107090,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T00:00:00Z","timestamp":1429747200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Siriraj Reseach Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00296-015-3271-8","type":"journal-article","created":{"date-parts":[[2015,4,22]],"date-time":"2015-04-22T12:27:25Z","timestamp":1429705645000},"page":"1693-1699","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis"],"prefix":"10.1007","volume":"35","author":[{"given":"Wanruchada","family":"Katchamart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajchara","family":"Koolvisoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emvalee","family":"Aromdee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveena","family":"Chiowchanwesawakit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chayawee","family":"Muengchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,23]]},"reference":[{"key":"3271_CR1","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JMW, Hobbs K, Huizinga TWJ, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, M\u00e9nard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsk\u00fd J, Wolfe F, Hawker G (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569\u20132581. doi: 10.1002\/art.27584","journal-title":"Arthritis Rheum"},{"key":"3271_CR2","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","volume":"146","author":"K Nishimura","year":"2007","unstructured":"Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, Saigo K, Morinobu A, Koshiba M, Kuntz KM, Kamae I, Kumagai S (2007) Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 146:797\u2013808","journal-title":"Ann Intern Med"},{"key":"3271_CR3","first-page":"11","volume":"32","author":"J Sun","year":"2014","unstructured":"Sun J, Zhang Y, Liu L, Liu G (2014) Diagnostic accuracy of combined tests of anti cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis: a meta-analysis. Clin Exp Rheumatol 32:11\u201321","journal-title":"Clin Exp Rheumatol"},{"key":"3271_CR4","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6","volume":"43","author":"EJ Kroot","year":"2000","unstructured":"Kroot EJ, de Jong BA, van Leeuwen MA, Swinkels H, van den Hoogen FH, van\u2019t Hof M, van de Putte LB, van Rijswijk MH, van Venrooij WJ, van Riel PL (2000) The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 43:1831\u20131835. doi: 10.1002\/1529-0131(200008)43:8<1831:aid-anr19>3.0.co;2-6","journal-title":"Arthritis Rheum"},{"key":"3271_CR5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1196\/annals.1313.031","volume":"1050","author":"A Greiner","year":"2005","unstructured":"Greiner A, Plischke H, Kellner H, Gruber R (2005) Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Ann N Y Acad Sci 1050:295\u2013303. doi: 10.1196\/annals.1313.031","journal-title":"Ann N Y Acad Sci"},{"key":"3271_CR6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/rheumatology\/kei203","volume":"45","author":"MA Quinn","year":"2006","unstructured":"Quinn MA, Gough AK, Green MJ, Devlin J, Hensor EM, Greenstein A, Fraser A, Emery P (2006) Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. Rheumatology 45:478\u2013480. doi: 10.1093\/rheumatology\/kei203","journal-title":"Rheumatology"},{"key":"3271_CR7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/03009740801998812","volume":"37","author":"H Guler","year":"2008","unstructured":"Guler H, Turhanoglu AD, Ozer B, Ozer C, Balci A (2008) The relationship between anti-cyclic citrullinated peptide and bone mineral density and radiographic damage in patients with rheumatoid arthritis. Scand J Rheumatol 37:337\u2013342. doi: 10.1080\/03009740801998812","journal-title":"Scand J Rheumatol"},{"key":"3271_CR8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10067-009-1337-2","volume":"29","author":"H Li","year":"2010","unstructured":"Li H, Song W, Li Y, Liu Y, Bai J, Li X, Mu F, Wang Y, Zhang F, Su L (2010) Diagnostic value of anti-cyclic citrullinated peptide antibodies in northern Chinese Han patients with rheumatoid arthritis and its correlation with disease activity. Clin Rheumatol 29:413\u2013417. doi: 10.1007\/s10067-009-1337-2","journal-title":"Clin Rheumatol"},{"key":"3271_CR9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10067-011-1820-4","volume":"31","author":"Y Ibn Yacoub","year":"2012","unstructured":"Ibn Yacoub Y, Amine B, Laatiris A, Hajjaj-Hassouni N (2012) Rheumatoid factor and antibodies against citrullinated peptides in Moroccan patients with rheumatoid arthritis: association with disease parameters and quality of life. Clin Rheumatol 31:329\u2013334. doi: 10.1007\/s10067-011-1820-4","journal-title":"Clin Rheumatol"},{"key":"3271_CR10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00296-010-1671-3","volume":"32","author":"K Shidara","year":"2012","unstructured":"Shidara K, Inoue E, Hoshi D, Sato E, Nakajima A, Momohara S, Taniguchi A, Yamanaka H (2012) Anti-cyclic citrullinated peptide antibody predicts functional disability in patients with rheumatoid arthritis in a large prospective observational cohort in Japan. Rheumatol Int 32:361\u2013366. doi: 10.1007\/s00296-010-1671-3","journal-title":"Rheumatol Int"},{"key":"3271_CR11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.62.2.120","volume":"62","author":"O Meyer","year":"2003","unstructured":"Meyer O, Labarre C, Dougados M, Goupille P, Cantagrel A, Dubois A, Nicaise-Roland P, Sibilia J, Combe B (2003) Anticitrullinated protein\/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis 62:120\u2013126","journal-title":"Ann Rheum Dis"},{"key":"3271_CR12","first-page":"281","volume":"24","author":"N Val del Amo del","year":"2006","unstructured":"del Val del Amo N, Ibanez Bosch R, Fito Manteca C, Gutierrez Polo R, Loza Cortina E (2006) Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness. Clin Exp Rheumatol 24:281\u2013286","journal-title":"Clin Exp Rheumatol"},{"key":"3271_CR13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"3271_CR14","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1007\/s00296-013-2749-5","volume":"33","author":"W Katchamart","year":"2013","unstructured":"Katchamart W, Ussavasodhi P, Chiowchanwesawakit P, Chanapai W (2013) Cross-cultural adaptation and validation of the Thai version of the Rheumatoid Arthritis Disease Activity Index (RADAI). Rheumatol Int 33:2503\u20132508. doi: 10.1007\/s00296-013-2749-5","journal-title":"Rheumatol Int"},{"key":"3271_CR15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/rheumatology\/40.5.555","volume":"40","author":"M Osiri","year":"2001","unstructured":"Osiri M, Deesomchok U, Tugwell P (2001) Evaluation of functional ability of Thai patients with rheumatoid arthritis by the use of a Thai version of the Health Assessment Questionnaire. Rheumatology 40:555\u2013558","journal-title":"Rheumatology"},{"key":"3271_CR16","doi-asserted-by":"crossref","first-page":"R129","DOI":"10.1186\/ar2796","volume":"11","author":"M Osiri","year":"2009","unstructured":"Osiri M, Wongchinsri J, Ukritchon S, Hanvivadhanakul P, Kasitanon N, Siripaitoon B (2009) Comprehensibility, reliability, validity, and responsiveness of the Thai version of the Health Assessment Questionnaire in Thai patients with rheumatoid arthritis. Arthritis Res Ther 11:R129","journal-title":"Arthritis Res Ther"},{"key":"3271_CR17","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/rheumatology\/keg184","volume":"42","author":"S Bas","year":"2003","unstructured":"Bas S, Genevay S, Meyer O, Gabay C (2003) Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology 42:677\u2013680","journal-title":"Rheumatology"},{"key":"3271_CR18","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/ard.2003.016808","volume":"63","author":"A Kastbom","year":"2004","unstructured":"Kastbom A, Strandberg G, Lindroos A, Skogh T (2004) Anti-CCP antibody test predicts the disease course during 3\u00a0years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis 63:1085\u20131089. doi: 10.1136\/ard.2003.016808","journal-title":"Ann Rheum Dis"},{"key":"3271_CR19","doi-asserted-by":"crossref","first-page":"R949","DOI":"10.1186\/ar1767","volume":"7","author":"AH Helm-van Mil van der","year":"2005","unstructured":"van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW (2005) Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 7:R949\u2013R958. doi: 10.1186\/ar1767","journal-title":"Arthritis Res Ther"},{"key":"3271_CR20","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1186\/ar2017","volume":"8","author":"D Mewar","year":"2006","unstructured":"Mewar D, Coote A, Moore DJ, Marinou I, Keyworth J, Dickson MC, Montgomery DS, Binks MH, Wilson AG (2006) Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis. Arthritis Res Ther 8:R128","journal-title":"Arthritis Res Ther"},{"key":"3271_CR21","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3899\/jrheum.131136","volume":"41","author":"JG Diffin","year":"2014","unstructured":"Diffin JG, Lunt M, Marshall T, Chipping JR, Symmons DPM, Verstappen SMM (2014) Has the severity of rheumatoid arthritis at presentation diminished over time? J Rheumatol 41:1590\u20131599. doi: 10.3899\/jrheum.131136","journal-title":"J Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-015-3271-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-015-3271-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-015-3271-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:28:30Z","timestamp":1559042910000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-015-3271-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,23]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["3271"],"URL":"https:\/\/doi.org\/10.1007\/s00296-015-3271-8","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,23]]}}}